The role was created to enhance partnerships and collaborations for clinical trials, according to a Jan. 21 hospital news release. In it, Dr. Weigel will lead initiatives to support pharma and biotechnology industry collaborations for trials sponsored by St. Jude.
Dr. Weigel most recently served as director of the pediatric hematology/oncology division at the Masonic Cancer Center and chief of staff for the University of Minnesota Medical Center, both in Minneapolis.
St. Jude’s portfolio includes more than 400 clinical trials, the release said.
